Hyundai Pharmaceutical Co., Ltd.

KRX:004310.KS

4025 (KRW) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Assets:
Current Assets:
Cash & Cash Equivalents 16,203.42630,266.15121,628.09613,272.3517,404.5287,361.7528,233.8838,621.62310,409.18513,790.38914,087.02816,266.78113,400.73911,319.6127,530.73312,874.56315,853.361
Short Term Investments 2,439.9944,268.076580.17,166.875-19,350.771-19,481.903-18,147.816-18,135.32100543.236343.236-1,855.601-1,747.37312031010,192.282
Cash and Short Term Investments 18,643.4234,534.22722,208.19620,439.2267,404.5287,361.7528,233.8838,621.62310,409.18513,790.38914,630.26416,610.01713,400.73911,319.6127,650.73313,184.56326,045.643
Net Receivables 39,301.03542,847.9440,604.14742,724.9945,660.04644,576.90261,489.78454,363.76647,404.00746,120.31544,875.46945,464.078052,590.45455,363.06348,864.38638,645.632
Inventory 26,997.98924,076.46622,021.74217,338.29117,645.81817,453.34817,206.119,437.30118,555.5819,358.58920,971.42924,099.85816,555.12614,026.0416,014.65714,128.48217,088.358
Other Current Assets 530.682184.06461.633-0.001-0.00100.0010-0.0010.0010.001-048,106.121-0.0010.001-0.0010.001
Total Current Assets 85,473.125101,642.69884,895.71880,502.50670,710.39169,392.00286,929.76882,422.69176,368.77179,269.29480,477.16386,173.95378,061.98677,936.10579,028.45476,177.4381,779.634
Non-Current Assets:
Property, Plant & Equipment, Net 29,435.53228,600.69329,261.14929,567.13630,592.2432,014.64533,000.13332,654.59332,454.13432,704.62633,345.92733,097.28144,176.24843,166.51246,320.28547,737.38435,429.096
Goodwill 00000000000000000
Intangible Assets 5,632.4417,301.47113,467.02612,541.128,058.5927,533.8013,796.1383,203.9991,749.1511,794.4271,828.822,411.272376.268378.926502.392687.141618.897
Goodwill and Intangible Assets 5,632.4417,301.47113,467.02612,541.128,058.5927,533.8013,796.1383,203.9991,749.1511,794.4271,828.822,411.272376.268378.926502.392687.141618.897
Long Term Investments 7,923.8566,796.69910,318.9852,893.91530,457.13931,839.36129,341.2330,573.976006,969.9017,435.3616,747.5537,191.0084,958.0581,877.609-7,729.769
Tax Assets 3,032.0343,492.2856,095.5145,424.8456,512.4795,242.5743,336.423,337.9590020,697.34220,701.437475.213377.56753.911113.628165.064
Other Non-Current Assets 23,132.11223,325.58319,819.02626,572.28384.07684.076-1,787.125-1,645.53535,965.71533,525.93183.57683.5762,152.9541,931.4873,404.614,108.63413,936.768
Total Non-Current Assets 69,155.97479,516.7378,961.69976,999.29975,704.52776,714.45767,686.79668,124.99170,16968,024.98462,925.56663,728.92753,928.23653,045.555,239.25654,524.39642,420.056
Total Assets 154,041.046181,159.428163,857.417157,501.806146,414.918146,106.459154,616.564150,547.682146,537.771147,294.278143,402.728149,902.88131,990.222130,981.604134,267.71130,701.827124,199.69
Liabilities & Equity:
Current Liabilities:
Account Payables 11,833.30518,071.78216,553.23812,693.01911,536.37512,952.05211,020.9799,906.817,273.848,488.3316,855.3415,561.2375,034.8773,162.435,133.0434,163.9263,215.24
Short Term Debt 38,624.26629,351.84914,520.50724,415.99521,00021,00029,453.10326,935.85521,00018,76420,749.8829,28620,00022,00023,521.67119,001.6030
Tax Payables 01,685.04800464.994414.263420.563124.95764.468217.38758.938315.9291,096.176678.22454.9401,706.071
Deferred Revenue 14,859.78819,978.1614,776.62814,669.71416,810.341414.2638,543.3057,681.4899,213.7618,685.9159,038.9328,972.56511,896.936678.2249,530.07210,151.9370
Other Current Liabilities 16.86913,293.799-0.00100.00115,138.2870000.0010.0010.0010.0019,632.5490.001-0.00112,985.203
Total Current Liabilities 65,334.22880,695.5945,850.37251,778.72949,346.71749,504.60349,017.38744,524.15437,487.60135,938.24736,644.15343,819.80336,931.81435,473.20338,184.78733,317.46516,200.443
Non-Current Liabilities:
Long Term Debt 580.64610,090.38315,324.285206.255-4,136.703000000000000
Deferred Revenue Non-Current 474.2583429,424.54,959.53,062.5000000000000
Deferred Tax Liabilities Non-Current 3,578.53,707.6556,657.93510,416.5424,136.7030451.843295.4941,489.5632,532.8141,931.6572,126.268696.774882.5588.1911,063.2581,843.092
Other Non-Current Liabilities 0-231.482-0010,581.3638,475.7017,048.9335,645.593,128.2164,136.7163,615.0094,270.0342,394.4442,121.0442,896.6453,690.0372,789.287
Total Non-Current Liabilities 4,633.40413,908.55731,406.7215,582.29713,643.8638,475.7017,500.7765,941.0834,617.7796,669.535,546.6666,396.3023,091.2183,003.5443,484.8364,753.2954,632.379
Total Liabilities 69,967.63294,604.14677,257.09267,361.02662,990.5857,980.30456,518.16350,465.23842,105.3842,607.77742,190.8250,216.10540,023.03238,476.74741,669.62338,070.7620,832.821
Equity:
Preferred Stock 00000000000000000
Common Stock 16,00016,00016,00016,00016,00016,00014,00014,00014,00014,00014,00014,00014,00014,00014,00014,00014,000
Retained Earnings 52,949.15149,601.68848,354.6552,291.9551,212.42752,832.99360,970.28174,723.30775,636.68274,794.57575,362.06474,235.65168,340.59868,406.27266,662.26366,590.60665,215.38
Accumulated Other Comprehensive Income/Loss 62,835.49664,273.24367,439.01269,342.16785,292.07588,662.37929,050.95490,539.742000000000
Other Total Stockholders Equity -46,529.971-43,319.65-45,193.337-47,493.336-69,080.165-69,369.218-5,922.834-79,180.60414,795.7115,891.92611,343.27810,989.2839,626.59210,098.58511,935.82312,040.46124,151.49
Total Shareholders Equity 85,254.67586,555.28186,600.32590,140.7883,424.33888,126.15598,098.401100,082.444104,432.391104,686.501100,705.34299,224.93491,967.1992,504.85792,598.08692,631.067103,366.87
Total Equity 85,254.67586,555.28186,600.32590,140.7883,424.33888,126.15598,098.401100,082.444104,432.391104,686.501101,211.90999,686.77591,967.1992,504.85792,598.08692,631.067103,366.87
Total Liabilities & Shareholders Equity 154,041.046181,159.428163,857.417157,501.806146,414.918146,106.459154,616.564150,547.682146,537.771147,294.278143,402.728149,902.88131,990.222130,981.604134,267.709130,701.827124,199.69